Fresenius SE & Co. KGaA (FSNUF)
USD 34.66
(0.0%)
USD 34.66
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.14 Billion EUR | -63.06% |
| 2022 | 3.5 Billion EUR | -15.63% |
| 2021 | 4.15 Billion EUR | -5.18% |
| 2020 | 4.38 Billion EUR | -5.31% |
| 2019 | 4.63 Billion EUR | -11.81% |
| 2018 | 5.25 Billion EUR | 14.43% |
| 2017 | 4.58 Billion EUR | 6.06% |
| 2016 | 4.32 Billion EUR | 11.66% |
| 2015 | 3.87 Billion EUR | 24.44% |
| 2014 | 3.11 Billion EUR | 4.11% |
| 2013 | 2.99 Billion EUR | 0.27% |
| 2012 | 2.98 Billion EUR | 16.39% |
| 2011 | 2.56 Billion EUR | 6.0% |
| 2010 | 2.41 Billion EUR | 17.72% |
| 2009 | 2.05 Billion EUR | 39.07% |
| 2008 | 1.47 Billion EUR | -8.2% |
| 2007 | 1.6 Billion EUR | 11.43% |
| 2006 | 1.44 Billion EUR | 49.02% |
| 2005 | 969 Million EUR | 14.67% |
| 2004 | 845 Million EUR | 8.19% |
| 2003 | 781 Million EUR | -6.69% |
| 2002 | 837 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 559 Million EUR | 203.8% |
| 2024 Q2 | 265 Million EUR | -52.59% |
| 2023 Q3 | 346 Million EUR | -36.28% |
| 2023 Q1 | 787 Million EUR | -9.95% |
| 2023 FY | 1.29 Billion EUR | -63.06% |
| 2023 Q2 | 543 Million EUR | -31.0% |
| 2023 Q4 | 184 Million EUR | -46.82% |
| 2022 Q1 | 902 Million EUR | -19.68% |
| 2022 Q3 | 887 Million EUR | 4.97% |
| 2022 Q4 | 874 Million EUR | -1.47% |
| 2022 FY | 3.5 Billion EUR | -15.63% |
| 2022 Q2 | 845 Million EUR | -6.32% |
| 2021 FY | 4.15 Billion EUR | -5.18% |
| 2021 Q1 | 1 Billion EUR | -1.76% |
| 2021 Q2 | 1.02 Billion EUR | 1.49% |
| 2021 Q3 | 1 Billion EUR | -1.27% |
| 2021 Q4 | 1.12 Billion EUR | 11.41% |
| 2020 Q4 | 1.02 Billion EUR | -8.0% |
| 2020 Q3 | 1.11 Billion EUR | -0.89% |
| 2020 Q1 | 1.12 Billion EUR | -11.35% |
| 2020 FY | 4.38 Billion EUR | -5.31% |
| 2020 Q2 | 1.12 Billion EUR | -0.18% |
| 2019 Q1 | 1.11 Billion EUR | -9.42% |
| 2019 FY | 4.63 Billion EUR | -11.81% |
| 2019 Q2 | 1.11 Billion EUR | 0.27% |
| 2019 Q3 | 1.12 Billion EUR | 0.98% |
| 2019 Q4 | 1.26 Billion EUR | 12.4% |
| 2018 FY | 5.25 Billion EUR | 14.43% |
| 2018 Q4 | 1.23 Billion EUR | 18.25% |
| 2018 Q3 | 1.04 Billion EUR | -46.42% |
| 2018 Q2 | 1.94 Billion EUR | 87.55% |
| 2018 Q1 | 1.03 Billion EUR | -5.13% |
| 2017 Q4 | 1.09 Billion EUR | -1.97% |
| 2017 FY | 4.58 Billion EUR | 6.06% |
| 2017 Q2 | 1.16 Billion EUR | -4.03% |
| 2017 Q1 | 1.21 Billion EUR | -1.54% |
| 2017 Q3 | 1.11 Billion EUR | -4.54% |
| 2016 Q1 | 959 Million EUR | -9.01% |
| 2016 FY | 4.32 Billion EUR | 11.66% |
| 2016 Q4 | 1.23 Billion EUR | 14.14% |
| 2016 Q3 | 1.08 Billion EUR | 2.95% |
| 2016 Q2 | 1.05 Billion EUR | 9.59% |
| 2015 Q4 | 1.05 Billion EUR | 4.05% |
| 2015 FY | 3.87 Billion EUR | 24.44% |
| 2015 Q2 | 935 Million EUR | 7.1% |
| 2015 Q1 | 873 Million EUR | 2.46% |
| 2015 Q3 | 1.01 Billion EUR | 8.34% |
| 2014 Q2 | 785 Million EUR | 18.22% |
| 2014 Q3 | 813 Million EUR | 3.57% |
| 2014 Q4 | 852 Million EUR | 4.8% |
| 2014 FY | 3.11 Billion EUR | 4.11% |
| 2014 Q1 | 664 Million EUR | -19.32% |
| 2013 Q1 | 689 Million EUR | -10.05% |
| 2013 Q3 | 747 Million EUR | 2.05% |
| 2013 Q4 | 823 Million EUR | 10.17% |
| 2013 FY | 2.99 Billion EUR | 0.27% |
| 2013 Q2 | 732 Million EUR | 6.24% |
| 2012 Q2 | 772 Million EUR | 16.79% |
| 2012 Q1 | 661 Million EUR | -5.71% |
| 2012 FY | 2.98 Billion EUR | 16.39% |
| 2012 Q4 | 766 Million EUR | -2.3% |
| 2012 Q3 | 784 Million EUR | 1.55% |
| 2011 Q4 | 701 Million EUR | 7.02% |
| 2011 Q1 | 575 Million EUR | -10.44% |
| 2011 FY | 2.56 Billion EUR | 6.0% |
| 2011 Q2 | 632 Million EUR | 9.91% |
| 2011 Q3 | 655 Million EUR | 3.64% |
| 2010 Q3 | 655 Million EUR | 5.99% |
| 2010 FY | 2.41 Billion EUR | 17.72% |
| 2010 Q1 | 500 Million EUR | -10.39% |
| 2010 Q4 | 642 Million EUR | -1.98% |
| 2010 Q2 | 618 Million EUR | 23.6% |
| 2009 Q4 | 558 Million EUR | 9.2% |
| 2009 Q3 | 511 Million EUR | 0.59% |
| 2009 Q2 | 508 Million EUR | 6.5% |
| 2009 Q1 | 477 Million EUR | 0.0% |
| 2009 FY | 2.05 Billion EUR | 39.07% |
| 2008 FY | 1.47 Billion EUR | -8.2% |
| 2007 FY | 1.6 Billion EUR | 11.43% |
| 2006 FY | 1.44 Billion EUR | 49.02% |
| 2005 FY | 969 Million EUR | 14.67% |
| 2004 FY | 845 Million EUR | 8.19% |
| 2003 FY | 781 Million EUR | -6.69% |
| 2002 FY | 837 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -25.84 Million USD | 4523.219% |
| Arem Pacific Corporation | -23.6 Thousand USD | 4843115.126% |
| Assisted 4 Living, Inc. | -121.58 Thousand USD | 940213.998% |
| BioCorRx Inc. | -3.78 Million USD | 30275.86% |
| Bionik Laboratories Corp. | -4.82 Million USD | 23788.928% |
| Banyan Corp. | -1.59 Million USD | 71811.708% |
| Clearday, Inc. | -11.85 Million USD | 9743.684% |
| Dental Patient Care America, Inc. | -31.55 Thousand USD | 3622117.302% |
| Quantum Medical Transport, Inc. | 222.84 USD | -512923971.082% |
| Empower Clinics Inc. | -4.95 Million USD | 23170.807% |
| First Choice Healthcare Solutions, Inc. | -2.41 Million USD | 47518.925% |
| Selectis Health, Inc. | -8.96 Million USD | 12856.1% |
| Ethema Health Corporation | -541.92 Thousand USD | 211016.74% |
| HealthLynked Corp. | -3.83 Million USD | 29929.712% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 43160.79% |
| JRSIS Health Care Corporation | -188.59 Thousand USD | 606150.966% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 67.1 Million USD | -1603.199% |
| MedSmart Group Inc. | -84.51 Thousand USD | 1352602.662% |
| North America Frac Sand, Inc. | -702.5 Thousand USD | 162804.626% |
| Nova Leap Health Corp. | 460.15 Thousand USD | -248296.182% |
| Nexteligent Holdings, Inc. | -201.72 Thousand USD | 566710.154% |
| PAO Group, Inc. | -45.42 Thousand USD | 2516612.55% |
| Primemd Inc. | 4.15 Million USD | -27384.18% |
| Raffles Medical Group Ltd | 87.71 Million USD | -1203.072% |
| Ryman Healthcare Limited | -26.98 Million USD | 4335.318% |
| Stem Cell Authority, Ltd. | -4230.00 USD | 27021376.596% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.25 Million USD | 50882.215% |
| Mycotopia Therapies, Inc. | -616.72 Thousand USD | 185434.12% |
| U.S. NeuroSurgical Holdings, Inc. | -765 Thousand USD | 149511.765% |
| Veltex Corporation | -1.08 Million USD | 105686.476% |
| World Financial Holding Group | -28.43 Thousand USD | 4020500.985% |
| Xcelerate Inc. | -2.61 Million USD | 43848.416% |